Latest News of CRL
FDA issues CRL to Astellas' IZERVAY sNDA for geographic atrophy
By Yahoo! Finance |
1 day ago
The FDA issued a complete response letter for Astellas Pharma's IZERVAY sNDA due to statistical concerns about proposed labelling language, not safety or efficacy. Astellas aims to address the issues ...
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
By Yahoo! Finance |
2 weeks ago
Charles River Laboratories International Inc (NYSE:CRL) displays strong financial performance despite revenue and operating income declines. The company's balance sheet remains robust, offering opport...
Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
By Yahoo! Finance |
2 months ago
The analyst price target for CRL is US$224, 5.5% below their fair value estimate....
-
Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment
By Yahoo! Finance | 2 months agoAriel Investments released its Q2 2024 investor letter for the Ariel Appreciation Fund, discussing the market surge driven by AI-themed stocks. The fund underperformed, mentioning Charles River Labora...
-
Those who invested in Charles River Laboratories International (NYSE:CRL) five years ago are up 50%
By Yahoo! Finance | 4 months agoCharles River Laboratories International, Inc. has seen its share price drop 18% in the last quarter but has grown 50% over five years. Despite recent declines, the company achieved 13% compound EPS g...